Boston Scientific (BSX) Work In Process (2009 - 2026)

Boston Scientific has disclosed Work In Process across 18 years of filings, most recently posting $277.0 million for Q2 2026.

• In Q2 2026, Work In Process rose 27.06% year-over-year to $277.0 million; the TTM figure through Jun 2026 stood at $277.0 million (up 27.06% YoY), while the FY2025 annual figure was $246.0 million, up 27.46% from the prior year.
• Work In Process came in at $277.0 million for Q2 2026 at Boston Scientific, up from $259.0 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $277.0 million in Q2 2026 to a low of $142.0 million in Q1 2022.
• Average Work In Process over 5 years is $196.9 million, with a median of $190.5 million recorded in 2024.
• Year-over-year, Work In Process rose 6.82% in 2024 and climbed 27.46% in 2025.
• Over 5 years, Work In Process stood at $147.0 million in 2022, then gained by 18.37% to $174.0 million in 2023, then grew by 10.92% to $193.0 million in 2024, then rose by 27.46% to $246.0 million in 2025, then advanced by 12.6% to $277.0 million in 2026.
• Per Business Quant data, the three most recent Work In Process figures were $277.0 million in Q2 2026, $259.0 million in Q1 2026, and $246.0 million in Q4 2025.